US 9855249
Isoxazole compounds and methods for the treatment of cystic fibrosis
granted A61KA61K31/42A61K31/422
Quick answer
US patent 9855249 (Isoxazole compounds and methods for the treatment of cystic fibrosis) held by Flatley Discovery Lab, LLC expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Flatley Discovery Lab, LLC
- Grant date
- Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/42, A61K31/422, A61K31/4439, A61K31/454